Utah Medical Products (UTMD) Gross Profit (2010 - 2026)

Utah Medical Products' Gross Profit history runs 17 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 4.62% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $21.7 million, a 5.11% decrease from a year earlier, with the FY2025 full-year figure at $22.0 million, down 8.87% from the prior year.
• Gross Profit was little changed at $5.3 million in Q1 2026 per UTMD's latest filing, from $5.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $8.3 million in Q4 2022 and bottomed at $5.3 million in Q4 2025.
• The 5-year median for Gross Profit is $6.8 million (2024), against an average of $6.7 million.
• Across the five-year window, Gross Profit gained 8.44% in 2022 and fell 25.01% in 2024, its largest moves.
• Year by year, Gross Profit stood at $8.3 million in 2022, then decreased by 14.76% to $7.1 million in 2023, then decreased by 25.01% to $5.3 million in 2024, then dropped by 1.11% to $5.3 million in 2025, then increased by 0.34% to $5.3 million in 2026.
• Per Business Quant, the three latest UTMD Gross Profit figures stand at $5.3 million (Q1 2026), $5.3 million (Q4 2025), and $5.6 million (Q3 2025).